Methadone Metabolite Rapid Test Kit,
EDDP Rapid Test Kit,
DOA Rapid Test Cassette
Methadone Metabolite (EDDP) Rapid Test Kit for Urine Sample DOA Rapid Test Cassette
Methadone Metabolite (EDDP) Rapid Test is a rapid, screening test for the qualitative detection of Metabolite and metabolites in human urine at specified cut off levels.
For professional use only.
For in vitro diagnostic use only.
Methadone Metabolite (EDDP) Rapid Test is an immuno-chromatographic assay for the qualitative determination of the presence of Methadone Metabolite(EDDP) listed in the table below.
2- ethylidene-1, 5-dimethyl-3,
This assay provides only a preliminary analytical test result. Gas Chromatography/Mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to Methadone Metabolite(EDDP) of abuse test result, particularly when preliminary positive results are indicated.
EDDP(2-Ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine) is the primary metabolite of methadone. Methadone is a synthetic analgesic drug that is originally used in the treatment of narcotic addicts. The detection of EDDP is more beneficial than traditional methadone screening since EDDP exists only in urine from individuals that ingested methadone. The tampering of specimens by spiking the urine with methadone can be prevented. Secondly, renal clearance of EDDP is not affected by urinary pH, therefore the EDDP test provides a more accurate result of methadone ingestion than the methadone parent screen.
Methadone Metabolite (EDDP) Rapid Test is a competitive immunoassay that is used to screen for the presence of Methadone Metabolite(EDDP) and metabolites in urine. It is chromatographic absorbent device in which, drugs within a urine sample, competitively combined to a limited number of drug monoclonal antibody (mouse) conjugate binding sites.
When the test is activated, the urine is absorbed into test by capillary action, mixes with the respective drug monoclonal antibody conjugate, and flows across a pre-coated membrane. When drug within the urine sample is below the detection level of the test, respective drug monoclonal antibody conjugate binds to the respective drug-protein conjugate immobilized in the Test Region (T) of the test . This produces a colored Test line in the Test Region (T) of the Test, which, regardless of its intensity, indicates a negative test result.
When sample drug levels are at or above the detection level of the test, the free drug in the sample binds to the respective drug monoclonal antibody conjugate, preventing the respective drug monoclonal antibody conjugate from binding to the respective drug-protein conjugate immobilized in the Test Region (T) of the device. This prevents the development of a distinct colored band in the test region,
indicating a preliminary positive result.
To serve as a procedure control, a colored line will appear at the Control Region (C) of Test, if the test has been performed properly.
【WARNINGS AND PRECAUTIONS】
Immunoassay for in vitro diagnostic use only.
Do not use after expiration date.
The test should remain in the sealed pouch until use.
The used test should be discarded according to local regulations.
【STORAGE AND STABILITY】
【INTERPRETATION OF RESULTS】
Preliminary positive (+)
Only one colored band appears, in the control region (C). No colored band appears in the test region (T).
Two colored bands appear on the membrane. One band appears in the control region (C) and another band appears in the test region (T).
Control band fails to appear. Results from any test which has not produced a control band at the specified read time must be discarded. Please review the procedure and repeat with a new test. If the problem persists, discontinue using the kit immediately and contact your local distributor.